This compound is a pharmaceutical intermediate specifically used in the manufacturing of Velpatasvir, a direct-acting antiviral agent. It is a sterically defined pyrrolidine derivative containing multiple ether and ester functional groups, as well as a tetrahydronaphthoisochromenone moiety.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
bu bileşiği satın almak mı istiyorsunuz?
Ücretsiz bir satın alma talebi yayınlayın — hesap gerekmez. Talebiniz bu ürünün tedarikçilerine ulaşır, yanıtlar doğrudan e-postanıza gelir.
(2S,4S)-2-(2-(9-Bromo-8-oxo-8,9,10,11-tetrahydro-5H-dibenzo[c,g]chromen-3-yl)-2-oxoethyl) 1-tert-butyl 4-(methoxymethyl)pyrrolidine-1,2-dicarboxylate
Velpatasvir synthetic intermediate
1,2-Pyrrolidinedicarboxylic acid, 4-cyano-, 1-(1,1-dimethylethyl) 2-methyl ester, (2S,4S)-
Pharmaceutical intermediate for Velpatasvir
9-bromo-3-(2-bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one
Pharmaceutical intermediate for Velpatasvir
3-acetyl-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one
Pharmaceutical intermediate for Velpatasvir
(5s)-1-(tert-butoxycarbonyl)-5-methyl-l-proline
Pharmaceutical intermediate for Velpatasvir
L-Proline, N-(methoxycarbonyl)-L-valyl-5-methyl-, 3-[2-[[[(2S,4S)-1-[(1,1-dimethylethoxy)carbonyl]-4-(methoxymethyl)-2-pyrrolidinyl]carbonyl]oxy]acetyl]-8,9,10,11-tetrahydro-8-oxo-5H-benzo[d]naphtho[2,3-b]pyran-9-yl ester, (5S)-
Velpatasvir intermediate
Tert-butyl (2S,4S)-2-[5-[6-[(2S,5S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaen-17-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate
Velpatasvir intermediate
Tert-butyl (2S,4S)-2-[5-[6-[(2S,5S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate
Pharmaceutical intermediate for Velpatasvir synthesis
1-O-tert-butyl 2-O-[2-oxo-2-(8-oxo-5,9,10,11-tetrahydronaphtho[2,3-c]isochromen-3-yl)ethyl] (2S,4S)-4-(methoxymethyl)pyrrolidine-1,2-dicarboxylate
RRSPSQSLZMAUSZ-BVZFJXPGSA-N
CC(C)(C)OC(=O)N1C[C@H](C[C@H]1C(=O)OCC(=O)C2=CC3=C(C=C2)C4=C(C=C5C(=C4)CCCC5=O)OC3)COC
—
bu bileşiği satın almak mı istiyorsunuz?
Ücretsiz bir satın alma talebi yayınlayın — hesap gerekmez. Talebiniz bu ürünün tedarikçilerine ulaşır, yanıtlar doğrudan e-postanıza gelir.